Astilbin Alleviates Gouty Arthritis via Regulating NLRP3 Inflammasome and NF-κB Signaling Pathway: A Comprehensive Study on In Vitro and In Vivo Experimental Models
Nutrients · 18.07.2026 · 18 (14) · 2360
DOI: 10.3390/nu18142360 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nutrients, online erschienen am 18.07.2026. Verfasst von Xiaoxi Zhang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Food Science and Nutrition, School of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou 310053, China. Hauptthemen laut MEDLINE: NLR Family, Pyrin Domain-Containing 3 Protein, Arthritis, Gouty, NF-kappa B, Signal Transduction. Die Arbeit nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Zhejiang Chinese Medical University, Joint TCM Science & Technology Projects of National Demonstration Zones for Comprehensive TCM Reform.
Abstract (Originalsprache)
Background/Objectives: Gouty arthritis (GA) is an inflammatory disease caused by increased purine metabolism. The limitations of current anti-GA therapies remain a major challenge. Astilbin, the main flavonoid in Smilax glabra Roxb., was found to exert potential anti-GA effects in our previous study.
Methods
In this study, a mouse model of monosodium urate (MSU)-induced arthritis and an inflammatory model using mouse bone marrow-derived macrophages (BMDMs) were established.
Results
Our data showed that astilbin reduced MSU-induced joint swelling and inflammatory infiltration in mice, restored lipopolysaccharide (LPS)/MSU-induced reductions in cell viability, and inhibited the expression levels of inflammatory factors IL-1β, IL-6 and TNF-α. Further studies showed that astilbin significantly reduced MSU-induced increases in NLRP3 and P-p65 protein levels, as well as the expression of ASC, P-IKKα, P-IκBα, and cleaved-caspase-1.
Conclusions
This study suggests that astilbin may be a promising natural product for the treatment of GA by inhibiting the activation of the NLRP3 inflammasome and NF-κB signaling pathway.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Food Science and Nutrition, School of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou 310053, China.
- Academy of Chinese Medical Sciences, Zhejiang Chinese Medical University, Hangzhou 310053, China.
ORCID-Profile: Daozong Xia
Förderung
- National Natural Science Foundation of China
- Zhejiang Chinese Medical University
- Joint TCM Science & Technology Projects of National Demonstration Zones for Comprehensive TCM Reform
- Zhejiang Province San-Nong-Jiu-Fang Science and Technology Cooperation Project
- Research Project of the Academy of Chinese Medical Sciences
- Academy of Chinese Medical Sciences
Zitieren
APA
Zhang, X., Fu, G., Zhao, X., Huang, Y., Li, F., & Xia, D. (2026). Astilbin Alleviates Gouty Arthritis via Regulating NLRP3 Inflammasome and NF-κB Signaling Pathway: A Comprehensive Study on In Vitro and In Vivo Experimental Models. Nutrients, 18(14), 2360. https://doi.org/10.3390/nu18142360
Vancouver
Zhang X, Fu G, Zhao X, Huang Y, Li F, Xia D. Astilbin Alleviates Gouty Arthritis via Regulating NLRP3 Inflammasome and NF-κB Signaling Pathway: A Comprehensive Study on In Vitro and In Vivo Experimental Models. Nutrients. 2026;18(14):2360. doi:10.3390/nu18142360
BibTeX
@article{Zhang2026,
author = {Zhang, Xiaoxi and Fu, Gaoyang and Zhao, Xinyu and Huang, Yan and Li, Fenfen and Xia, Daozong},
title = {Astilbin Alleviates Gouty Arthritis via Regulating NLRP3 Inflammasome and NF-κB Signaling Pathway: A Comprehensive Study on In Vitro and In Vivo Experimental Models},
journal = {Nutrients},
year = {2026},
volume = {18},
number = {14},
pages = {2360},
doi = {10.3390/nu18142360}
}
EUVIMED